Please assess the completion status of the following clinical trial:

Trial Title: Mass-balance Study of [14C]-APD421 in Healthy Volunteers

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy males~* Age 18 to 65 years of age at time of signing informed consent~* Body mass index (BMI) of 18 to 30 kg/m2 or, if outside the range, considered not clinically significant by the investigator~* Must be willing and able to communicate and participate in the whole study~* Must provide written informed consent~* Must agree to use an adequate method of contraception (as defined in Section 8.4)~* Must have regular bowel movements (ie average stool production of ≥1 and ≤3 stools per day)~Exclusion Criteria:~* Prior participation in another study with a radiation burden of \> 0.1 mSv and ≤ 1 mSv in the period of 1 year prior to screening; a radiation burden of \> 1 mSv and ≤ 2 mSv in the period of 2 years prior to screening; a radiation burden of \> 2 mSv and ≤ 3 mSv in the period of 3 years prior to screening, etc (add 1 year per 1 mSv)

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- 14C-APD421 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).